HR 7658 · 117th Congress · Health

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Introduced 2022-05-03· Sponsored by Rep. O'Halleran, Tom [D-AZ-1]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2022-05-03)

Plain Language Summary

[AI summary unavailable — showing source text] This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Republican
Rep. Lesko, Debbie [R-AZ-8]AZ